Sharp- Moving Major Drug Manufacturers – Star Scientific (STSI), Keryx (KERX), Horizon Pharma (HZNP)
Massapequa Park – March 20, 2013 — (Net PR News) -King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today, we bring a special trend analysis of the following stocks: Star Scientific, Inc. (NASDAQ:STSI), Keryx Biopharmaceuticals (NASDAQ:KERX), Horizon PharmaInc(NASDAQ:HZNP)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
Star Scientific, Inc. (NASDAQ:STSI) declined -17.17% and closed at $1.64 in the last trading session with the total traded volume of 6.27 million shares. That’s more than the average volume of 1.36 million. The sharp decline was seen on Tuesday after the company said it is being investigated by the federal government.
Is STSI a Solid Investment at These Levels? Read This Report For Details
The U.S. Attorney’s Office for the Eastern District of Virginia issued subpoenas to the company, its directors and others. The company disclosed that it thinks the key focal point of the investigation is its securities, including private placements and related transactions dating to 2006. The company plans to cooperate fully with the investigation and was responding to the subpoenas, according to a form filed with the Securities and Exchange Commission.
STSI is now trading above its 50 day moving average of -23.98% and 200 day moving average of -49.37%. It has outstanding shares of 166.35 million with the total market cap of $272.81 million and its beta value stands at 2.07 times, which shows that the stock is more volatile.
Keryx Biopharmaceuticals (NASDAQ:KERX) fell -2.56% to close at $7.20 and its overall volume in the last trading session was 2.00 million shares, less than the average volume of 6.35 million. Levi & Korsinsky recently commenced a class action lawsuit in the United States District Court for the Southern District of New York on behalf of shareholders who acquired shares of Keryx Biopharmaceuticals, Inc. between June 1, 2009 and April 1, 2012.
How Should Investors Trade KERX Now? Don’t Miss out a Special Trend Analysis
KERX hit the day high price of $7.43 and day low of $7.10. The stock is trading with positive year-to-date performance of +174.85%. It has a current ratio of 2.71. The company has a total market cap of $588.18 million.
Horizon PharmaInc(NASDAQ:HZNP) increased +6.17% to close at $2.58 in the last trading session and its total traded volume was 1.05 million shares, beating the average volume of 535,456. The $158.89M company recently released quarterly results and, in other news, Piper Jaffray reiterated its neutral rating on the stock.
What Are HZNP’s Charts Signaling for Traders? Find Out Here
It has earnings per share of -$6.14, net profit margin of -854.23% and operating margin of -890.23%. The stock has positive year-to-date performance of +10.73% and is trading above its 50 day moving average of +11.41% and 200 day moving average of -29.35%.
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/